NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

I don't have the links for you. The median OS for SoC has been a bit higher than what NWBO cites as their target, and maybe 25-30% survival at 24 months. The survival curves for dc-vax treatment might track fairly close to SoC until 20-24 months but with SoC patients die off heavily and 30-36 month survival of much more than 10% would be exceptional. It is precisely in that part of the curve where successful IO treatment becomes clear with death rates much slower than SoC. The size of that difference plus the number of longer term (> 2 year, > 3 year etc) is the very convincing proof that the vaccines work, when they do. Showing a SS difference in the median is possibly dicey even if the vaccine is very effective.